Description
A thiamine antimetabolite; converted by thiamine pyrophosphokinase to oxythiamine pyrophosphate; decreases transketolase activity in and is cytotoxic to MDA-MB-231 breast cancer cells at 5 mM; inhibits the nonoxidative synthesis of ribose and decreases RNA and DNA synthesis in MIA PaCa-2 pancreatic cancer cells at 0.5 µM; induces cell cycle arrest at the G0/G1 phase and apoptosis in an Ehrlich murine spontaneous adenocarcinoma model; reduces tumor growth in an SMMC mouse xenograft model in combination with sorafenib; has been used to induce thiamine deficiency in mice
Formal name: 3-[(1,6-dihydro-2-methyl-6-oxo-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)-4-methyl-thiazolium, monochloride, monohydrochloride
Synonyms:
Molecular weight: 338.3
CAS: 614-05-1
Purity: ≥95%
Formulation: A solid